Hubei Minkang Pharmaceutical Ltd. Closes Private Placement of $791,189
15 Mayo 2012 - 3:05PM
Marketwired
Hubei Minkang Pharmaceutical Ltd. (OTCBB:HBMK) ("Hubei Minkang" or
the "Company") is pleased to announce that it has recently closed
on a private placement of 1,130,270 shares of common stock of the
Company at $0.70 per share, for total gross proceeds of
$791,189.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy securities. The securities offered
and sold in the private placement have not been registered under
the United States Securities Act of 1933, as amended (the
"Securities Act"), or any state securities laws, and may not be
offered or sold in the United States absent registration, or an
applicable exemption from registration under the Securities Act and
applicable state securities laws.
About Hubei Minkang
Hubei Minkang Pharmaceutical Ltd. is a modern pharmaceutical
enterprise that produces and markets Traditional Chinese Medicines
and some chemical pharmaceuticals in China as well as markets its
products to the US, Japan, Canada, Singapore, Malaysia, Thailand
and Hong Kong among other countries. Hubei Minkang's main
facilities are located in Yichang, Hubei, China.
FORWARD-LOOKING STATEMENTS: This news release may include
"forward-looking statements" regarding Hubei Minkang Pharmaceutical
Ltd. and its subsidiaries, business and project plans. Such
forward-looking statements are within the meaning of Section 27A of
the Securities Act of 1933, as amended, and section 21E of the
United States Securities and Exchange Act of 1934, as amended, and
are intended to be covered by the safe harbor created by such
sections. Where Hubei Minkang Pharmaceutical Ltd. expresses or
implies an expectation or belief as to future events or results,
such expectation or belief is believed to have a reasonable basis.
However, forward-looking statements are subject to risks,
uncertainties and other factors, which could cause actual results
to differ materially from future results expressed, projected or
implied by such forward-looking statements. Hubei Minkang
Pharmaceutical Ltd. does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
Contacts: Hubei Minkang Pharmaceutical Ltd. +65-6747-7883
Hubei Minkang Pharmaceut... (GM) (USOTC:HBMK)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Hubei Minkang Pharmaceut... (GM) (USOTC:HBMK)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Hubei Minkang Pharmaceutical Ltd (GM) (OTCMarkets): 0 recent articles
Más de Hubei Minkang Pharmaceutical Ltd. Artículos de Noticias